SLRX stock forecast
Our latest prediction for Salarius Pharmaceuticals, Inc.'s stock price was made on the Feb. 19, 2020 when the stock price was at 0.96$.
In the short term (2weeks), SLRX's stock price should outperform the market by 10.14%. During that period the price should oscillate between -12.88% and +34.55%.
In the medium term (3months), SLRX's stock price should outperform the market by 20.75%. During that period the price should oscillate between -47.22% and +85.71%.Get email alerts
About Salarius Pharmaceuticals, Inc.
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius' clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need. The company was founded in 2014 and is headquartered in Houston, TX.
At the moment the company generates 3M USD in revenues.
On its last earning announcement, the company reported a loss of -4.43$ per share.
The book value per share is 2.16$
Three months stock forecastFeb. 19, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|